Eldridge Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History

Eldridge Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $6,848 - $8,109	100 Added 2.93%	3,512 $253,000
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $187,045 - $218,675	3,412 New	3,412 $201,000
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $196,742 - $233,266	-4,600 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$45.12 - $53.8 $27,072 - $32,280	600 Added 15.0%	4,600 $220,000
Q4 2018 Jan 24, 2019	BUY	$48.76 - $63.23 $195,040 - $252,920	4,000 New	4,000 $208,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Eldridge Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Eldridge Investment Advisors, Inc. with notifications on news.